270EGP
- Active ingredient
- gemcitabine
- Strength
- 200mg /5.26ml
- Form
- vial
- Manufacturer
- sedico
- Route
- injection
Uses
Used in the treatment of various cancers including bladder, pancreatic, lung, breast, and ovarian cancers. Intravesical formulations may be used for certain non-muscle invasive bladder cancers.
Do not use if
Contraindicated in patients with hypersensitivity to gemcitabine or formulation components.
Side effects
Myelosuppression, fatigue, nausea, vomiting, fever, urinary symptoms, and elevated liver enzymes may occur.
Warnings
May cause severe bone marrow suppression, pulmonary toxicity, and serious infections. Monitor blood counts regularly.
How it works
Nucleoside antimetabolite that inhibits DNA synthesis and prevents proliferation of rapidly dividing cells.
Storage
Store at 20–25°C in the original container and handle as a hazardous drug.